Clinical Scorecard: Fostering an Interventional Glaucoma Culture

At a Glance

Key Highlights

• Interventional glaucoma represents a shift from managing glaucoma solely with eye drops to earlier procedural interventions that reduce patient burden and improve long-term outcomes.
• Practice culture transformation requires education and alignment of all staff members, including coordinators trained in clinical and financial aspects to support patient decision-making.
• Coordinators play a pivotal role in empowering patients by addressing common concerns about timing, costs, and treatment benefits, fostering trust and adherence.

Guideline-Based Recommendations

Diagnosis

• Recognize that stable intraocular pressure today does not preclude the need for early intervention to preserve long-term vision.

Management

• Consider SLT as a first-line treatment for many patients as it is quick, insurance-covered, and can reduce dependence on eye drops.
• Utilize minimally invasive glaucoma surgeries and sustained-release drug implants to provide longer-lasting pressure control less dependent on patient compliance.

Monitoring & Follow-up

• Continuously educate and train staff to maintain consistent messaging and patient support regarding interventional glaucoma options.
• Engage in regular practice huddles and updates to incorporate new technologies and coverage guidelines.

Risks

• Address patient concerns about side effects, costs, and compliance challenges associated with long-term eye drop therapy.
• Mitigate risks of vision loss due to inconsistent drop use by promoting earlier procedural interventions.

Patient & Prescribing Data

Glaucoma patients traditionally managed with multiple daily eye drops who face challenges with compliance, side effects, and costs.

Early interventional treatments like SLT and MIGS can stabilize intraocular pressure, reduce drop burden, and potentially lower long-term costs, improving patient quality of life and adherence.

Clinical Best Practices

• Train coordinators extensively in both clinical rationale and financial aspects to effectively counsel patients.
• Embed continuous education on interventional glaucoma into onboarding and regular staff meetings to sustain a culture of early intervention.
• Ensure all practice members, from front desk to billing, understand and support the interventional glaucoma care pathway.
• Use clear, empathetic communication to shift patient mindset from fear of lifelong drops to empowerment through early procedural options.
• Align marketing, referral outreach, and billing processes to reinforce the practice’s commitment to advanced glaucoma care.

References